Özsütçü, MustafaBalcı, ÖzlemTanrıverdi, CaferDemirci, Göktuğ10.07.20192019-07-1010.07.20192019-07-102017Özsütçü, M., Balcı, Ö., Tanrıverdi, C. ve Demirci, G. (2017). Efficacy of adjunctive mitomycin C in transcanalicular diode laser dacryocystorhinostomy. European Archives of Oto-Rhino-Laryngology, 274(2), 873-877. https://dx.doi.org/10.1007/s00405-016-4308-70937-44771434-4726https://dx.doi.org/10.1007/s00405-016-4308-7https://hdl.handle.net/20.500.12511/2373WOS: 000394351800037PubMed ID: 27664138The objective of the study was to compare the success rate of transcanalicular laser dacryocystorhinostomy (TCL-DCR) with or without the use of adjunctive mitomycin C (MMC) in cases with primary nasolacrimal duct obstruction (NLDO). This retrospective study was comprised of 68 patients with uncomplicated primary NLDO. There were two groups in the study: the Group 1 (n = 35) patients underwent TCL-DCR surgery with MMC and the Group 2 (n = 33) patients underwent TCL-DCR surgery without MMC. All patients had bicanalicular silicone tube intubation. The main outcome measures were patent osteotomy as visualized endoscopically and patent nasolacrimal irrigation. The follow-up period was 12 months. All patients had unilateral TCL-DCR with silicone tube intubation. Six months following surgery, the silicone tubes were removed. At the final evaluation, success rates were 80 % in Group 1 and 78.8 % in Group 2. There was no statistically significant difference between the two groups (p = 0.52). No complications related to MMC usage were recorded during the study period. Intraoperative use of MMC has no beneficial effect on the success rate in TCL-DCR.eninfo:eu-repo/semantics/openAccessNasolacrimal Duct ObstructionMitomycin CTranscanalicular Laser DacryocystorhinostomyArticle274287387710.1007/s00405-016-4308-7Q2Q2